Actavis Announces Trial Results
Company reveals outcome of Topline Phase 3 Clinical Trial for Single-Dose DALVANCE' (dalbavancin) in the Treatment of ABSSSI
(UK) Pharmaceutical Industry Regulation Undermines NICE Drugs Appraisal Work
Government continues to subvert the efficiency of technology.
Revolutionary New Concept of Heart Disease Threatens End of Global Statin Market
Dr. Rath Research Institute: Revolutionary new concept of heart disease threatens end of global statin market
First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients
Merrimack Pharmaceuticals, Inc. has announced updated clinical data from a multi-arm Phase 1 study of MM-141, a bispecific antibody targeting
BCM-95 Curcumin and BosPure Boswellia in Prevention and Treatment of Colorectal Cancer
In the first study of its kind, researchers have demonstrated novel and previously unknown mechanisms of action
Are Mobile Medical Apps Good for our Health?
The study, revealed today, looks into the use of mobile health apps.
5 Million Euros for Medical Innovation
All seven research projects are in line with the roadmap of the Dutch Top Sector.